Phil Franchina, Author at American Parkinson Disease Association

Walking Separately, but Together

Posted on June 12, 2020June 25, 2020 by Phil Franchina

The 2020 Optimism Walk season kicked-off with four virtual Optimism Walks which all took place...see more simultaneously on May 31, 2020. After an online celebration and opening ceremony, participants in all four events walked separately, but together in solidarity for the PD community. Due to social distancing, participants were encouraged to walk […]

Staying Connected While Social Distancing

Posted on June 12, 2020June 25, 2020 by Phil Franchina

Challenges often force us to adapt and learn new ways of doing things....see more No one knows that better than people living with Parkinson’s disease (PD). Facing new challenges As COVID-19 became a reality and communities implemented social distancing guidelines, the American Parkinson Disease Association (APDA) faced some significant challenges. […]

Sing for PD

Posted on June 12, 2020June 25, 2020 by Phil Franchina

The APDA National Headquarters was filled with song as people with PD sang their hearts out...see more during our first-ever class in March. A program of the Mark Morris Dance Group, focuses on breathing and vocal technique, rhythm, melody, song interpretation, and creativity. Instructor Joseph Peterson took […]

Helping People with Parkinson’s Disease Overcome Barriers

Posted on June 12, 2020 by Phil Franchina

People with PD who are from underserved communities — those who...see more are low income, speak English as a second language, live in rural areas, or are members of minority groups often face unique barriers that affect their access to quality care. Through a generous grant from Neurocrine […]

Ask the Doctor/Q&A with Dr. Rebecca Gilbert

Posted on June 12, 2020June 24, 2020 by Phil Franchina

Ask the Doctor/Q&A with Dr. Rebecca Gilbert Q: I have heard about gene therapy for Parkinson’s disease. What...see more is this and how do I know if I am a good candidate for this? A: Gene therapy is a category of potential treatments in which a genetically-engineered virus, which contains a small fragment of DNA, […]

American Parkinson Disease Association RESPONDS TO COVID-19 WITH SUPPORT FROM ADIRA FOUNDATION

Posted on June 9, 2020June 9, 2020 by Phil Franchina

APDA Receives Adira’s Fast-Trask Response Grant to...see more Assist People With Parkinson’s Disease During Pandemic NEW YORK, NY – June 9, 2020 — The American Parkinson Disease Association (APDA) has been supporting people living with Parkinson’s disease (PD) for more than 60 years. However, […]

A statement from APDA in this time of unrest

Posted on June 2, 2020July 13, 2023 by Phil Franchina

All of us at the American Parkinson Disease Association (APDA) support equality for all and reject racism. Our programs...see more are open to everyone and we foster a safe and welcoming place for all to join us, whether virtually or in person. Disparities and injustice exist on many levels, including within the healthcare system. At APDA, […]

New medication approved by FDA for OFF symptoms

Posted on May 22, 2020July 13, 2023 by Phil Franchina

Kynmobi Sunovion Pharmaceuticals announced that the Food and Drug Administration (FDA) approved Kynmobi® (apomorphine hydrochloride), a new sublingual medication...see more for fast relief of OFF symptoms of Parkinson’s disease (PD). Apomorphine acts as a dopamine agonist, mimicking the effects of dopamine in the brain. It was previously only available as Apokyn, an injectable medication that provides […]

THE AMERICAN PARKINSON DISEASE ASSOCIATION (APDA) KICKS-OFF 2020 NATIONAL OPTIMISM WALK SERIES

Posted on May 7, 2020May 7, 2020 by Phil Franchina

*New VIRTUAL Walks Added* Thousands Band Together...see more Across the Country to Help People with Parkinson’s Live Life to the Fullest NEW YORK, NY, May 7, 2020 – The American Parkinson’s Disease Association (APDA) officially announces the full schedule for the 2020 APDA Optimism Walks […]

New drug approved for OFF episodes

Posted on April 27, 2020July 13, 2023 by Phil Franchina

Today, Neurocrine Biosciences announced that the Food and Drug Administration (FDA) approved ONGENTYS ® (opicapone), a new medication for...see more treatment of Parkinson’s disease (PD). Opicapone is a catechol-O-methyltransferase (COMT) inhibitor to be used once-daily as an add-on treatment to levodopa for patients who are experiencing OFF time with their current medication regimen. Opicapone is in […]

What is Parkinson’s Disease?

Living with Parkinson’s Disease

Parkinson’s Resource Library

Research

Ways to Give

Walking Separately, but Together

Staying Connected While Social Distancing

Sing for PD

Helping People with Parkinson’s Disease Overcome Barriers

Ask the Doctor/Q&A with Dr. Rebecca Gilbert

American Parkinson Disease Association RESPONDS TO COVID-19 WITH SUPPORT FROM ADIRA FOUNDATION

A statement from APDA in this time of unrest

New medication approved by FDA for OFF symptoms

THE AMERICAN PARKINSON DISEASE ASSOCIATION (APDA) KICKS-OFF 2020 NATIONAL OPTIMISM WALK SERIES

New drug approved for OFF episodes

She was diagnosed with Parkinson’s at 27. These were her warning signs.

Wearable Devices for Parkinson’s Disease: The Future Is Here

Food as Medicine: Diet’s Role in Parkinson’s Disease

Is Parkinson’s Disease Hereditary?

AMERICAN PARKINSON DISEASE ASSOCIATION FREE TWO-DAY VIRTUAL CONFERENCE RETURNS TO EDUCATE, EMPOWER, AND ENGAGE THE PD COMMUNITY

Making Hope Possible: American Parkinson Disease Association Supports Researchers With $2.6 Million in New Funding

AMERICAN PARKINSON DISEASE ASSOCIATION CELEBRATES THE NATIONAL PLAN TO END PARKINSON'S ACT BECOMING LAW

AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES NEW RESOURCES AVAILABLE IN MANDARIN & SIMPLIFIED CHINESE

ONAPGO: A Newly-Approved Medication for OFF Periods in Parkinson’s

EPA Bans TCE, a Solvent Linked to PD

Vyalev: A Newly-Approved Medication for Parkinson’s Disease Motor Fluctuations

Adaptive DBS – a new approach to improve PD symptoms

Support Our Mission

Support Our Mission

Subscribe to get updates from APDA and helpful Parkinson’s info!